Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines

Atzori, Laura
Membro del Collaboration Group
;
2018-01-01

Abstract

Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or generalized bullous lesions. In up to 20% of affected patients blister may be completely absent, and only excoriations, prurigo-like lesions, eczematous lesions, urticated lesions, and/or infiltrated plaques are observed. The disease is significantly associated with neurological disorders. The morbidity of bullous pemphigoid and its impact on the quality of life are significant. So far, a limited number of national treatment guidelines have been proposed, but no common European consensus has emerged. This guideline for the treatment of bullous pemphigoid has been developed by an Italian group of experts taking in account the Italian legislation and local pharmacological governance. Guidelines are adapted from the original article under the guidance of the European Dermatology Forum (EDF) in collaboration with the European Academy of Dermatology and Venereology (EADV). It summarizes evidence-based and expert-based recommendations (S2 level).
2018
Inglese
153
3
305
315
11
https://www.minervamedica.it/en/getfreepdf/4NxfKwDec8f4%252B6wQpqVL28zsQZjBDBfqX3Uf5hbkGUfKAzl8esgKsLqpyhsaR22bqGqA1mjXEry9S4mxKSROYQ%253D%253D/R23Y2018N03A0305.pdf
Esperti anonimi
internazionale
scientifica
Bullous pemphigoid; Guideline; Quality of life; Rare diseases; 2708
no
Cozzani, Emanuele; Marzano, Angelo V.; Caproni, Marzia; Feliciani, Claudio; Calzavara-Pinton, Piergiacomo; Alaibac, Mauro; Antiga, Emiliano; Arisi, Ma ...espandi
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
73
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Questionario e social

Condividi su:
Impostazioni cookie